Effect of ventricular fibrillation on infarct size after myocardial infarction: a translational study
- PMID: 39579225
- PMCID: PMC11628572
- DOI: 10.1007/s00395-024-01091-9
Effect of ventricular fibrillation on infarct size after myocardial infarction: a translational study
Abstract
Ventricular fibrillation (VF)-induced cardiac arrest frequently complicates ST-segment elevation myocardial infarction (STEMI). Although larger infarct sizes (IS) correlate with a higher risk of VF, the influence of VF itself on IS has remained poorly investigated. To address this knowledge gap, we analyzed the effect of VF on IS in patients and two experimental models. From a prospective cohort, 30 STEMI patients with VF were matched 1:2 with STEMI patients without VF on the common determinants of IS. The primary endpoint was IS, assessed using the 48-h area under the curve (AUC) for troponin. We also compared IS in pigs with/without spontaneous VF during STEMI (n = 15/group), and in an isolated rat heart model of myocardial infarction with/without electrically induced VF (n = 7/group). After matching, the patient characteristics, including the area at risk (AR), were similar. IS was 33% lower in the VF group compared to the control group (troponin AUC 1.6 [0.5-3.3] 106 arbitrary units vs. 2.4 [0.9-4.1] 106 arbitrary units; p < 0.05), but infarct scar size (assessed using MRI and ECG) did not differ between the groups at 1 and 6 months. In both experimental models, IS, expressed as a percentage of AR, was lower (p < 0.05) in the VF group than in the control group. When common determinants of IS are comparable, VF occurring prior to myocardial infarction reperfusion appears to be associated with smaller IS. Nevertheless, this finding, observed under specific experimental conditions and in a highly selected group of patients, was not associated with reduced infarct scar size.Registration (HIBISCUS-STEMI cohort): ClinicalTrials.gov NCT05794022.
Keywords: Cardiac arrest; Infarct size; Ischemia–reperfusion injury; Myocardial infarction; Ventricular fibrillation.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflict of interests: The authors reports that they have no relationships relevant to the contents of this paper to disclose.
Figures



References
-
- Bell RM, Mocanu MM, Yellon DM (2011) Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 50:940–950. 10.1016/j.yjmcc.2011.02.018 - PubMed
-
- Bochaton T, Leboube S, Paccalet A, Crola Da Silva C, Buisson M, Mewton N, Amaz C, Varillon Y, Bonnefoy-Cudraz E, Rioufol G, Cho T-H, Ovize M, Bidaux G, Nighoghossian N, Mechtouff L (2022) Impact of age on systemic inflammatory profile of patients with ST-Segment-Elevation Myocardial Infarction and acute ischemic stroke. Stroke 53:2249–2259. 10.1161/STROKEAHA.121.036806 - PubMed
-
- Bøtker HE (2020) The future of cardioprotection-pointing toward patients at elevated risk as the target populations. J Cardiovasc Pharmacol Ther 25:487–493. 10.1177/1074248420937871 - PubMed
-
- Cenko E, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Krljanac G, Kalpak O, Ricci B, Milicic D, Manfrini O, Van Der Schaar M, Badimon L, Bugiardini R (2018) Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med 178:632–639. 10.1001/jamainternmed.2018.0514 - PMC - PubMed
-
- Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P (1987) Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase Clinical findings through hospital discharge. Circulation 76:142–154. 10.1161/01.cir.76.1.142 - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous